Medtronic
![TAVR devices equal surgery in long-term trials | Pharmtales](https://pharmtales.com/wp-content/uploads/2023/10/Medtronic-Edwards-TAVR-devices-match-surgery-in-long-term-studies.jpg)
Medtronic, Edwardsâ TAVR devices match surgery in long-term studies
Anika Sharma
At the Transcatheter Cardiovascular Therapeutics conference in San Francisco, both Medtronic and Edwards Lifesciences unveiled the latest results from ongoing ...
![Medtronic to sell its medical supplies unit to Carlyle Group for $7 billion](https://pharmtales.com/wp-content/uploads/2023/10/Medtronic-to-sell-its-medical-supplies-unit-to-Carlyle-Group-for-7-billion.jpg)
Medtronic to sell its medical supplies unit to Carlyle Group for $7 billion
Anika Sharma
In a significant development nearly a year after Medtronic’s announcement of its intention to spin off its patient monitoring and ...
![ReCor Medical, Hypertension, Medtronic, FDA](https://pharmtales.com/wp-content/uploads/2023/08/FDA-Advisors-Favor-Otsukas-ReCor-and-Express-Reservations-on-Medtronics-Renal-Denervation-Therapies.jpg)
FDA Advisors Favor Otsuka’s ReCor and Express Reservations on Medtronic’s Renal Denervation Therapies
Anika Sharma
During a two-day-long FDA meeting, a panel of advisors deliberated over competing proposals for novel renal denervation therapies, ultimately granting ...
![Medtronic, layoff, Medical device, Medtronic revenue growth, Medtronic layoffs,](https://pharmtales.com/wp-content/uploads/2023/08/Medtronics-Layoffs-Earlier-This-Year-Propel-Broad-Based-Revenue-Growth.jpg)
Medtronic’s Layoffs Earlier This Year Propel Broad-Based Revenue Growth
Anika Sharma
Medtronic Commences FY2024 with Encouraging Single-Digit Sales Growth Across Divisions Following Strategic Cost Reduction Measures Medtronic, a prominent player in ...